Journal: Marine Drugs
Article Title: Chondroitin Sulfate Nanovectorized by LC-PUFAs Nanocarriers Extracted from Salmon ( Salmo salar ) by Green Process with Decreased Inflammatory Marker Expression in Interleukin-1β-Stimulated Primary Human Chondrocytes In Vitro Culture
doi: 10.3390/md22120571
Figure Lengend Snippet: The effect of nanoliposomes/CS exposure on IL-1β-stimulated MMPs. Human chondrocytes were stimulated or not with 1 ng/mL IL-1β and exposed to nanoliposomes (250 µg/mL) or nanoliposomes and CS extracts (250 µg/mL+ 25 µg/mL). For ( A , B , E ), total RNA was extracted after 24 h stimulation then reverse transcribed into cDNA and analyzed by RT-PCR. The relative abundance of MMP1, MMP3, and MMP13 mRNAs was normalized to RP29 mRNA. Comparison was performed using the ΔCt method with the fold value of reference = 1. The results shown are the mean ± SD of at least four individual experiments (*: p < 0.01 vs. control; #: p < 0.01 vs. IL-1β). For ( C , D , F ) levels of MMP1, 3, and 13 after 48 h of stimulation (*: p < 0.01 vs. control; #: p < 0.01 vs. IL-1β).
Article Snippet: After stimulations, supernatants were collected and centrifuged 5 min at 600 g and analyses were performed according to the kit manufacturer’s instructions for MMP1, MMP3, and MMP13 levels (DuoSet ® ELISA, R&D systems, Abingdon, UK—Human Total MMP1, Human Total MMP3, and Human Pro-MMP13) and PGE2 levels (Prostaglandin E2 Parameter Assay Kit, Bio-Techne, Abingdon, UK).
Techniques: Reverse Transcription, Reverse Transcription Polymerase Chain Reaction, Comparison, Control